Terry Murdock
Chief Operating Officer bij G1 THERAPEUTICS, INC.
Vermogen: 447 716 $ op 31-03-2024
Profiel
Terry L.
Murdock is currently the Chief Operating Officer at G1 Therapeutics, Inc. He previously worked as the Executive Director-Global Clinical Operations at Ergomed Plc.
From 2001 to 2012, he held the position of Senior Vice President-Clinical Operations at ILEX Oncology, Inc. He also served as the VP & Global Head-Oncology Center for Excellence at IQVIA Holdings, Inc. from 2014 to 2017.
Prior to that, he was the Vice President-Research at The US Oncology Network from 1995 to 2001.
Mr. Murdock completed his undergraduate and graduate degrees at The University of Texas at Austin.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
G1 THERAPEUTICS, INC.
0.20% | 04-01-2024 | 103 638 ( 0.20% ) | 447 716 $ | 31-03-2024 |
Actieve functies van Terry Murdock
| Bedrijven | Functie | Begin |
|---|---|---|
| G1 THERAPEUTICS, INC. | Chief Operating Officer | 01-01-2019 |
Eerdere bekende functies van Terry Murdock
| Bedrijven | Functie | Einde |
|---|---|---|
| IQVIA HOLDINGS INC. | Corporate Officer/Principal | 01-07-2017 |
ILEX Oncology, Inc.
 ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Chief Operating Officer | 01-05-2012 |
| The US Oncology Network | Corporate Officer/Principal | 01-01-2001 |
| ERGOMED | Chief Tech/Sci/R&D Officer | - |
Opleiding van Terry Murdock
| The University of Texas at Austin | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| G1 THERAPEUTICS, INC. | Health Technology |
| ERGOMED | Commercial Services |
| IQVIA HOLDINGS INC. | Health Services |
| Bedrijven in privébezit | 2 |
|---|---|
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Health Technology |
| The US Oncology Network |
